BCDA

Biocardia, Inc. is a clinical-stage regenerative medicine company based in San Carlos, California, dedicated to pioneering innovative therapies for cardiovascular diseases. The company specializes in the development of advanced cellular therapies and delivery systems aimed at improving patient outcomes in heart conditions, effectively targeting significant unmet medical needs within the cardiovascular sector. With a strong pipeline and a commitment to integrating cutting-edge technologies, Biocardia is poised for strategic growth as it nears critical clinical milestones and explores potential commercialization opportunities, positioning itself to revolutionize cardiovascular treatment paradigms.